Compliance Rate

Compliance Rate 59.0%
Compliant submissions 59
Incompliant submissions 41
Total trials 100

Your Clinical Trials

Showing 75 of 100 entries
View as:

Acute Otitis Media: Adjuvant Therapy to Improve Outcome

Phase: N/A Priority: Normal
NCT ID: NCT00000363 Org: User:
Start: - End: 06/30/01 Due: 06/30/02

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000663 Org: User:
Start: - End: - Due: -

Predictive Values of Serotonergic Alterations for Outcome - 2

Phase: N/A Priority: Normal
NCT ID: NCT00000313 Org: User:
Start: - End: - Due: -

Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00000503 Org: User:
Start: 08/31/82 End: 10/31/87 Due: 10/31/88

Alternate-Day Buprenorphine Administration. Phase IV - 5

Phase: N/A Priority: Normal
NCT ID: NCT00000223 Org: User:
Start: 06/30/93 End: - Due: -

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

Phase: N/A Priority: Normal
NCT ID: NCT00000683 Org: User:
Start: - End: 06/30/93 Due: 06/30/94

Multicenter Investigation of Limitation of Infarct Size (MILIS)

Phase: N/A Priority: Normal
NCT ID: NCT00000493 Org: User:
Start: 09/30/77 End: 12/31/85 Due: 12/31/86

Coronary Drug Project Mortality Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT00000483 Org: User:
Start: 06/30/81 End: 03/31/85 Due: 03/31/86

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000883 Org: User:
Start: 10/31/97 End: 04/30/07 Due: 04/30/08

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00000853 Org: User:
Start: - End: 01/31/99 Due: 01/31/00

Cord Blood Stem Cell Transplantation Study (COBLT)

Phase: N/A Priority: Normal
NCT ID: NCT00000603 Org: User:
Start: 09/30/96 End: 10/31/07 Due: 10/31/08

Ondansetron Treatment for Alcoholism

Phase: N/A Priority: Normal
NCT ID: NCT00000443 Org: User:
Start: - End: 04/30/00 Due: 04/30/01

Treatment of Obsessive-Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00000373 Org: User:
Start: 09/30/92 End: 07/31/03 Due: 07/31/04

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000793 Org: User:
Start: - End: 10/31/97 Due: 10/31/98

Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children

Phase: N/A Priority: Normal
NCT ID: NCT00000383 Org: User:
Start: 09/30/97 End: 09/30/02 Due: 09/30/03

Alternate Day Buprenorphine Administration, Phase X - 15

Phase: N/A Priority: Normal
NCT ID: NCT00000233 Org: User:
Start: 05/31/93 End: - Due: -

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00000633 Org: User:
Start: - End: 10/31/98 Due: 10/31/99

Osteoporosis Prevention in Preadolescent Girls

Phase: N/A Priority: Normal
NCT ID: NCT00000413 Org: User:
Start: 07/31/98 End: 06/30/02 Due: 06/30/03

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00000763 Org: User:
Start: - End: 02/28/97 Due: 02/28/98

Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?

Phase: N/A Priority: Normal
NCT ID: NCT00000473 Org: User:
Start: 07/31/89 End: 06/30/94 Due: 06/30/95

HDL-Atherosclerosis Treatment Study (HATS)

Phase: N/A Priority: Normal
NCT ID: NCT00000553 Org: User:
Start: 09/30/94 End: 02/28/01 Due: 02/28/02

Montreal Heart Attack Readjustment Trial (M-HART)

Phase: N/A Priority: Normal
NCT ID: NCT00000533 Org: User:
Start: 02/29/92 End: 12/31/96 Due: 12/31/97

Evaluation of Benztropine for Cocaine Craving - 2

Phase: N/A Priority: Normal
NCT ID: NCT00000333 Org: User:
Start: 05/31/01 End: 04/30/03 Due: 04/30/04

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000673 Org: User:
Start: - End: 05/31/93 Due: 05/31/94

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

Phase: N/A Priority: Normal
NCT ID: NCT00000933 Org: User:
Start: - End: 07/31/00 Due: 07/31/01